Compared to both HC and PCHC, AAB concentrations against ADRA2A, ADRB2, STAB1, and CXCR3 significantly decrease in both PCS/non-ME/CFS and PCS/ME/CFS (Figure 2A). The gene discussed is ADRA2A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.